| Heading: |
Achalasia: Health Services |
| Question ID: |
1744450 |
| UIN: |
15949 |
| House: |
Commons |
| Date tabled: |
2024-11-25 |
| Asking Member ID: |
5141 |
| Asking Member display name: |
Alex Mayer
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Alex Mayer
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if his Department will make an assessment of the potential merits of amending the Rare Diseases Framework to include provisions for improving patient-centred care pathways for Achalasia. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Government is committed to improving the lives of those living with rare diseases, such as achalasia. The UK Rare Diseases Framework sets out four priorities, collaboratively developed with the rare disease community, which include better coordination... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |